Company / Return on Assets (ROA)
AYTU BIOPHARMA, INC Return on Assets (ROA) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-10.9%
FY2025
5-year range
-79.0% / -10.9%
FY2021-FY2025
Trend
+18.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -150.1% in FY2017 to -8.9% in FY2020.
Based on SEC 10-K filings.
-10.9% in FY2025 with a 10-year CAGR of +31.6%.
Improved from -12.5% to -10.9% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +68.1pp
- 5-Year Change
- -2.0pp
- 10-Year Change
- +31.6pp
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 18.6% year-over-year.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.9% | +18.6% |
| FY2024 | -13.4% | -7.4% |
| FY2023 | -12.5% | +84.2% |
| FY2022 | -79.0% | -260.3% |
| FY2021 | -21.9% | -146.8% |
| FY2020 | -8.9% | +81.6% |
| FY2018 | -48.4% | +67.8% |
| FY2017 | -150.1% | -29.6% |
| FY2016 | -115.8% | -172.6% |
| FY2015 | -42.5% | +99.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026